Oct 4
|
The benefits of using a nimble platform from phase to phase
|
Oct 4
|
FDA lifts clinical hold on Avidity’s lead antibody conjugate therapy trial
|
Oct 4
|
FDA greenlights OrthAlign’s handheld Lantern Hip navigation system
|
Oct 4
|
MILOS study: The real-world use of bempedoic acid
|
Oct 4
|
Island Pharmaceuticals trials prevention and therapy benefit of dengue drug
|
Oct 4
|
Over a third of global insurance consumers are ready for AI
|
Oct 4
|
Jakson Green secures $476m to expand renewables portfolio
|
Oct 4
|
NHS proposes phased launch for Eli Lilly’s Mounjaro
|
Oct 4
|
Retailers must adapt to Gen Z and Gen Alpha preferences
|
Oct 4
|
FDA clears FluMist nasal influenza vaccine for self-administration
|
Oct 4
|
BEV discounting boosts UK car market
|
Oct 4
|
Biggest influencers in lodgings in Q3 2020: The top individuals to follow
|
Oct 4
|
Total prevalent cases of dry eye syndrome soar in China
|
Oct 4
|
New tech set to disrupt payments sector
|
Oct 4
|
2022 forecast: decentralised trials to reach new heights with 28% jump
|
Oct 4
|
Thailand credit and charge card payments market to grow by 7.1% in 2024, forecasts GlobalData
|
Oct 3
|
Resolution scores $83m to develop macrophage cell therapies
|
Oct 3
|
Chronic diseases “as urgent as climate change,” says Novo Nordisk CSO
|
Oct 3
|
Palisades steam generators require repair before restart, nuclear authority says
|
Oct 3
|
Women are dying unnecessarily due to the underdiagnosis of heart disease
|